TopGLP1

Mounjaro vs Ozempic

For type 2 diabetes, Mounjaro (tirzepatide) and Ozempic (semaglutide) are the headline options. Both lower blood sugar and drive weight loss; tirzepatide's dual mechanism tends to produce more of both, but semaglutide has deep outcome data.

Last reviewed 2026-09-01 by the TopGLP1 Editorial Team

Educational, not medical advice. This page explains GLP-1 medications in general terms. Only a licensed clinician who knows your history can decide what's right for you.

Our take: Mounjaro

For A1C reduction and weight loss combined, Mounjaro (tirzepatide) tends to edge Ozempic — but both are excellent, and Ozempic has the longer cardiovascular-outcomes record.

Choose Mounjaro if…

you want maximum combined A1C and weight reduction.

Choose Ozempic if…

you want the longest track record and established cardiovascular-outcome data.

Side by side

MounjaroOzempic
MoleculeTirzepatide (GIP/GLP-1)Semaglutide (GLP-1)
Approved forType 2 diabetesType 2 diabetes
Weight loss (secondary)Higher on averageStrong
DosingWeekly, 2.5 → 15 mgWeekly, up to 2.0 mg
Cardiovascular dataMaturingEstablished (SELECT in obesity)
Weight-loss siblingZepboundWegovy

How they compare on results

In diabetes trials, tirzepatide has generally delivered strong A1C reductions plus more weight loss than semaglutide, reflecting its dual GIP/GLP-1 action. Semaglutide remains highly effective and is backed by extensive outcome data.

For many patients the choice comes down to coverage, tolerability and whether maximum weight loss (favoring Mounjaro) or the longest track record (favoring Ozempic) matters more.

Side effects & safety

Comparable GI side effects and the same class warnings. In diabetes, watch for low blood sugar when combined with insulin or sulfonylureas.

Cost

Both are branded diabetes drugs, often covered by insurance for type 2 diabetes; cash prices are high. Compounded tirzepatide/semaglutide are cheaper but are used for weight loss, not as diabetes substitutes without clinician guidance.

Estimate your costCheapest options

Full drug guides

Mounjaro guide Ozempic guide

Mounjaro vs Ozempic: common questions

Head-to-head diabetes data generally favor tirzepatide (Mounjaro) for A1C reduction and weight loss, though both are very effective.

Sources & references

Clinical figures on this page trace to peer-reviewed trials and official regulators. We link the primary record so you can verify it yourself.

  1. 1.
  2. 2.
  3. 3.